Viatris VTRS Generics — Finite-lived intangible assets, net

Similar metrics at other companies

OLEDOther Finite Lived Intangible Assets Net

$3.67M—

ASLEAsset Management Solutions — Finite Lived Intangible Assets Net

$2.97M—

QNSTNon Us — Finite Lived Intangible Assets Net

$48.4M—

CBUOther Finite Lived Intangible Assets Net

$40.26M-2.5%

ELACorporate — Finite Lived Intangible Assets Net

$298.54K-15.8%

HELEFinite Lived Intangible Assets - Gross

$570.84M—

Questions, answered.

What is Viatris's generics — finite-lived intangible assets, net?

Viatris (VTRS) reported generics — finite-lived intangible assets, net of $1.29B in Q4 2025.

How has Viatris's generics — finite-lived intangible assets, net changed year-over-year?

Viatris's generics — finite-lived intangible assets, net decreased by 18.0% year-over-year, from $1.57B to $1.29B.

What does generics — finite-lived intangible assets, net mean?

This metric measures the net book value of identifiable intangible assets with finite useful lives, such as product rights, patents, and trademarks, specifically attributed to the generics business segment. It represents the capitalized costs of acquiring or developing these assets, adjusted for accumulated amortization and impairment charges. Investors monitor this to understand the company's investment in its product pipeline and the potential future amortization expense impact on earnings.